News AZ pays Heptares $10m as cancer trial begins Phase 1 study of immuno-oncology drug candidate begins.
News Genzyme and AZ fall foul of UK pharma code Companies named in adverts after breaching code of practice.
News AZ suing US regulator to prevent Crestor generics Firm also licenses two dermatology drugs to LEO Pharma.
News AZ's Zavicefta antibiotic approved in Europe New combination antibiotic for serious Gram-negative bacterial infections in hospitals.
News Senju launches first-in-class dry eye disease drug in Japan Senju has launched a new drug for dry eye disease (DED) in Japan, Avarept, the first drug in the TRPV1 antagonist class to reach the market.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
